Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC

[1] Siegel RL(2019)Cancer statistics, 2019 CA A Cancer Journal for Clinicians 69 7-34

[2] Miller KD(1994)Epidemiology and risk factors for head and neck cancer Semin. Oncol. 21 281-288

[3] Jemal A(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-386

[4] Spitz MR(2019)A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany Cancer Med 11 9-22

[5] Ferlay J(2011)The molecular biology of head and neck cancer Nat Rev Cancer 206 233-242

[6] Soerjomataram I(2017)Predictive factors for outcome and quality of life in HPV-positive and HPV-negative HNSCC Recent Results Cancer Res 21 870-881

[7] Dikshit R(2015)Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes Clin Cancer Res 17 440-451

[8] Eser S(2016)Development and validation of a staging system for HPV-related oropharyngeal cancer by the international collaboration on oropharyngeal cancer network for staging (ICON-S): a multicentre cohort study Lancet Oncol 7 565-574

[9] Mathers C(2006)Reassessment of the role of induction chemotherapy for head and neck cancer Lancet Oncol 123 100-105

[10] Rebelo M(2003)Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma Acta Otolaryngol 324 1670-1673

[1] Siegel RL(2019)Cancer statistics, 2019 CA A Cancer Journal for Clinicians 69 7-34

[2] Miller KD(1994)Epidemiology and risk factors for head and neck cancer Semin. Oncol. 21 281-288

[3] Jemal A(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-386

[4] Spitz MR(2019)A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany Cancer Med 11 9-22

[5] Ferlay J(2011)The molecular biology of head and neck cancer Nat Rev Cancer 206 233-242

[6] Soerjomataram I(2017)Predictive factors for outcome and quality of life in HPV-positive and HPV-negative HNSCC Recent Results Cancer Res 21 870-881

[7] Dikshit R(2015)Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes Clin Cancer Res 17 440-451

[8] Eser S(2016)Development and validation of a staging system for HPV-related oropharyngeal cancer by the international collaboration on oropharyngeal cancer network for staging (ICON-S): a multicentre cohort study Lancet Oncol 7 565-574

[9] Mathers C(2006)Reassessment of the role of induction chemotherapy for head and neck cancer Lancet Oncol 123 100-105

[10] Rebelo M(2003)Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma Acta Otolaryngol 324 1670-1673